Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity
Veterinary Dermatology · 2023
DOI: 10.1111/vde.13189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Dermatology, 2023. Verfasst von Alexandra Moore und 4 weiteren Autor:innen. Beteiligte Einrichtung: Animal Dermatology Clinic Perth, The Animal Hospital Murdoch University, Murdoch, Western Australia, Australia. Hauptthemen laut MEDLINE: Insect Bites and Stings, Bee Venoms, Hypersensitivity, Anaphylaxis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hymenoptera envenomation occurs frequently in people and dogs and can trigger anaphylaxis. Venom immunotherapy (VIT) is the only preventive treatment for Hymenoptera hypersensitivity and is indicated for people with severe adverse reactions to insect stings. Rush VIT is an accelerated VIT protocol in people. This has not been reported in dogs.
Objectives
The objective of the study was to evaluate the safety of modified rush VIT. Animals Twenty client‐owned dogs with Hymenoptera hypersensitivity based on a history of adverse reactions to Hymenoptera envenomation and a positive intradermal test to honey bee and/or paper wasp venom. Materials and Methods Dogs received incremental doses of venom via subcutaneous injection one day per week for three consecutive weeks until the maintenance dose was achieved. Vital signs were recorded every 30 min prior to venom administration. Adverse reactions were categorised as localised or grade I–IV systemic reactions.
Results
Nineteen of 20 dogs (95%) completed rush VIT. One dog experienced a grade III systemic adverse reaction and was withdrawn from the study. No adverse reactions occurred in 10 of 20 dogs (50%). Localised and grade I–II systemic reactions occurred in nine of 20 dogs (45%), including nausea (n = 5), injection site pruritus (n = 3) and diarrhoea and lethargy (n = 1). Conclusions and Clinical Relevance Modified rush VIT in dogs was well‐tolerated and should be considered for dogs with Hymenoptera hypersensitivity. Larger studies are needed to evaluate the efficacy of VIT in dogs for preventing hypersensitivity reactions to insect stings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Animal Dermatology Clinic Perth, The Animal Hospital Murdoch University, Murdoch, Western Australia, Australia.
- Animal Dermatology Clinic, Tustin, California, USA.
- Animal Dermatology Clinic, Marina del Rey, California, USA.
- College of Veterinary Medicine, The Animal Hospital Murdoch University, Murdoch, Western Australia, Australia.
ORCID-Profile: Wayne S Rosenkrantz
Zitieren
APA
Moore, A., Burrows, A. K., Rosenkrantz, W. S., Ghubash, R. M., & Hosgood, G. (2023). Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity. Veterinary Dermatology. https://doi.org/10.1111/vde.13189
Vancouver
Moore A, Burrows AK, Rosenkrantz WS, Ghubash RM, Hosgood G. Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity. Veterinary Dermatology. 2023. doi:10.1111/vde.13189
BibTeX
@article{Moore2023,
author = {Moore, Alexandra and Burrows, Amanda K and Rosenkrantz, Wayne S and Ghubash, Rudayna M and Hosgood, Giselle},
title = {Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity},
journal = {Veterinary Dermatology},
year = {2023},
doi = {10.1111/vde.13189}
}
EUVIMED